| Product Code: ETC9880761 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Uganda HER2 Testing Market Overview |
3.1 Uganda Country Macro Economic Indicators |
3.2 Uganda HER2 Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Uganda HER2 Testing Market - Industry Life Cycle |
3.4 Uganda HER2 Testing Market - Porter's Five Forces |
3.5 Uganda HER2 Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.6 Uganda HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Uganda HER2 Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Uganda HER2 Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2-positive breast cancer cases in Uganda |
4.2.2 Growing awareness about the importance of HER2 testing for personalized treatment |
4.2.3 Technological advancements in HER2 testing methods |
4.3 Market Restraints |
4.3.1 Limited access to HER2 testing facilities in remote areas of Uganda |
4.3.2 High cost associated with HER2 testing procedures |
4.3.3 Lack of skilled healthcare professionals for accurate HER2 testing and interpretation |
5 Uganda HER2 Testing Market Trends |
6 Uganda HER2 Testing Market, By Types |
6.1 Uganda HER2 Testing Market, By Technique |
6.1.1 Overview and Analysis |
6.1.2 Uganda HER2 Testing Market Revenues & Volume, By Technique, 2021- 2031F |
6.1.3 Uganda HER2 Testing Market Revenues & Volume, By Fluorescence In Situ Hybridization, 2021- 2031F |
6.1.4 Uganda HER2 Testing Market Revenues & Volume, By Dual-Probe, 2021- 2031F |
6.1.5 Uganda HER2 Testing Market Revenues & Volume, By Single-Probe, 2021- 2031F |
6.1.6 Uganda HER2 Testing Market Revenues & Volume, By Chromogenic In Situ Hybridization (CISH), 2021- 2031F |
6.1.7 Uganda HER2 Testing Market Revenues & Volume, By Silver-Enhanced In Situ Hybridization, 2021- 2031F |
6.2 Uganda HER2 Testing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Uganda HER2 Testing Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Uganda HER2 Testing Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.3 Uganda HER2 Testing Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Uganda HER2 Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Uganda HER2 Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Uganda HER2 Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Uganda HER2 Testing Market Import-Export Trade Statistics |
7.1 Uganda HER2 Testing Market Export to Major Countries |
7.2 Uganda HER2 Testing Market Imports from Major Countries |
8 Uganda HER2 Testing Market Key Performance Indicators |
8.1 Number of HER2 testing facilities in Uganda |
8.2 Percentage increase in HER2 testing rates annually |
8.3 Adoption rate of advanced HER2 testing technologies |
8.4 Percentage of healthcare professionals trained in HER2 testing techniques |
8.5 Patient satisfaction with HER2 testing services |
9 Uganda HER2 Testing Market - Opportunity Assessment |
9.1 Uganda HER2 Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.2 Uganda HER2 Testing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Uganda HER2 Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Uganda HER2 Testing Market - Competitive Landscape |
10.1 Uganda HER2 Testing Market Revenue Share, By Companies, 2024 |
10.2 Uganda HER2 Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |